Neoadjuvant Radiochemotherapy Combined with Panitumumab in Locally Advanced KRAS wild-type Rectal Cancer

Next Previous
Trial Profile

Neoadjuvant Radiochemotherapy Combined with Panitumumab in Locally Advanced KRAS wild-type Rectal Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 11 May 2015

At a glance

  • Drugs Panitumumab (Primary) ; Antineoplastics
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Acronyms NEOREC-1

    • Most Recent Events

    • 06 May 2015 Status changed from suspended to completed as reported by ClinicalTrials.gov record.
    • 06 May 2015 Status changed from suspended to completed as reported by ClinicalTrials.gov record.
    • 10 Sep 2012 Planned End Date changed from 1 Apr 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top